Comparison of entecavir and adefovir for the treatment of chronic hepatitis B

Autor: Si-Hai Zhao, En-Qi Liu, Da-Xin Cheng, Ya-Feng Li, Yan-Li Wang, Yu-Long Chen, Wen-Tao Sun, Xi-Cai Yan, Shuang-Suo Dang

Publikováno v: Brazilian Journal of Infectious Diseases, Vol 16, Iss 4, Pp 366-372

The results of several new clinical trials that compared the effectiveness of entecavir (ETV) treatment with that of adefovir (ADV) treatment in patients with chronic hepatitis B (CHB) were published in recent years. However, the numbers of patients

Externí odkaz: https://doaj.org/article/77ff5d59b6004c5cb6b631c979c8fd48

Comparison of entecavir and adefovir for the treatment of chronic hepatitis B

Autor: Shuangsuo Dang, Xi-Cai Yan, Wen-Tao Sun, Daxin Cheng, Yafeng Li, Yulong Chen, Enqi Liu, Sihai Zhao, Yanli Wang

Publikováno v: Brazilian Journal of Infectious Diseases v.16 n.4 2012
Brazilian Journal of Infectious Diseases
Brazilian Society of Infectious Diseases (BSID)
instacron:BSID
Brazilian Journal of Infectious Diseases, Vol 16, Iss 4, Pp 366-372
Brazilian Journal of Infectious Diseases, Volume: 16, Issue: 4, Pages: 366-372, Published: AUG 2012

The results of several new clinical trials that compared the effectiveness of entecavir (ETV) treatment with that of adefovir (ADV) treatment in patients with chronic hepatitis B (CHB) were published in recent years. However, the numbers of patients

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bacd4897d49f2f41033714d88bf24608
https://doi.org/10.1016/j.bjid.2012.06.016